Abstract
The c-Src non-receptor tyrosine kinase is overexpressed in a large number of human malignancies. It is linked to tumour development and progression to distant metastases by promoting cell proliferation, invasion, and motility. Recently, promising anticancer therapeutics targeting c-Src have been developed that are under clinical investigation.
Preview
Unable to display preview. Download preview PDF.
References
Bowman T, Broome MA, Sinibaldi D, Wharton W, Pledger WJ, Sedivy JM, Irby R, Yeatman T, Courtneidge SA, Jove R (2001) Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis. Proc Natl Acad Sci USA 98:7319–7324
Brown MT, Cooper AJ (1996) Regulation, substrates and functions of src. Biochim Biophys Acta 1287:121–149
Chang JH, Gill S, Settleman J, Parsons S (1995) c-Src regulates the simultaneous rearrangement of actin cytoskeleton, p190RhoGAP, and p120rasGAP following epidermal growth factor stimulation. J Cell Biol 130:355–368
Cooper JA, Gould KL, Cartwright CA, et al. (1986) Tyr527 is phosphorylated in pp60c-src: implications for regulation. Science 231:1431–1434
Courtneidge SA, Dhand R, Pilat D, Twamley GM, Waterfield MD, Roussel MF (1993) Activation of Src family kinases by colony stimulating factor-1, and their association with its receptor. EMBO J 12:943–950
Czernilofsky AP, Levinson AD, Varmus HE, Bishop JM, Tischer E, Goodman HM (1980) Nucleotide sequence of an avian sarcoma virus oncogene (src) and proposed amino acid sequence for gene product. Nature 287:198–203
DeMali KA, Godwin SL, Soltoff SP, et al. (1999) Multiple roles for Src in a PDGF-stimulated cell. Exp Cell Res 253:271–279
Duxbury MS, Ito H, Zinner MJ, et al. (2004a) Inhibition of SRC tyrosine kinase impairs inherent and acquired gemcitabine resistance in human pancreatic adenocarcinoma cells. Clin Cancer Res 10:2307–2318
Duxbury MS, Ito H, Zinner MJ, et al. (2004b) siRNA directed against c-Src enhances pancreatic adenocarcinoma cell gemcitabine chemosensitivity. J Am Coll Surg 198:953–959
Frame MC (2002) Src in cancer: deregulation and consequences for cell behaviour. Biochim Biophys Acta 1602:114–130
Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Löchner D, Birchmeier W (1991) E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113:173–185
Fujita Y, Krause G, Scheffner M, Zechner D, Leddy HE, Behrens J, Sommer T, Birchmeier W (2002) Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat Cell Biol 4:222–231
Golas JM, Arndt K, Etienne C, et al. (2003) SKI-606, a 4-anilino-3-quinolinecarbonitrile dual inhibitor of Src and Abl kinases, is a potent antiproliferative agent against chronic myelogenous leukemia cells in culture and causes regression of K562 xenografts in nude mice. Cancer Res 63:375–381
Golas JM, Arndt K, Etienne C, et al. (2005) SKI-606, a Src/Abl inhibitor with in vivo activity in colon tumor xenograft models. Cancer Res 65:5358–5364
Green TP, Fennel M, Whittaker R, et al. (2004) Preclinical activity of AZD0530, a novel oral potent and selective inhibitor of Src family kinases. Eur J Cancer 2:A361
Huebner RJ, Todaro GJ (1969) Oncogenes of RNA tumor viruses as determinants of cancer. Proc Natl Acad Sci USA 64:1087–1094
Irby RB, Mao W, Coppola D, Kang J, Loubeau JM, Trudeau W, Karl R, Fujita DJ, Jove R, Yeatman TJ (1999) Activating SRC mutation in a subset of advanced human colon cancers. Nat Genet 21:187–190
Ito H, Gardner-Thorpe J, Zinner MJ, et al. (2003) Inhibition of tyrosine kinase Src suppresses pancreatic cancer invasiveness. Surgery 134:221–226
Jamora C, Fuchs E (2002) Intercellular adhesion, signalling and the cytoskeleton. Nat Cell Biol 4:E101–E108
Johnson LN, Noble ME, Owen DJ (1996) Active and inactive protein kinases: structural basis for regulation. Cell 85:149–158
Jung EJ, Kim CW (2002) Interaction between chicken protein tyrosine phosphatase 1 (CPTP1)-like rat protein phosphatase 1 (PTP 1) and p60(v-src) in v-src transformed Rat-1 fibroblasts. Exp Mol Med 34:476–480
Kilarski WW, Jura N, Gerwins P (2003) Inactivation of Src family kinases inhibits angiogenesis in vivo: implications for a mechanism involving organization of the actin cytoskeleton. Exp Cell Res 291:70–82
Kim M, Tezuka T, Tanaka K, et al. (2004) Cbl-c suppresses v-Src induced transformation through ubiquitin-dependent protein degradation. Oncogene 23:1645–1655
Landgren E, Blume-Jensen P, Courtneidge SA, Claesson-Welsh L (1995) Fibroblast growth factor receptor-1 regulation of Src family kinases. Oncogene 10:2027–2035
Laukaitis CM, Webb DJ, Donais K, Horwitz AF (2001) Differential dynamics of α-actinin during formation of disassembly of adhesions in migrating cells. J Cell Biol 153:1427–1440
Lutz MP, Esser IB, Flossmann-Kast BB, et al. (1998) Overexpression and activation of the tyrosine kinase Src in human pancreatic cancer. Biochem Biophys Res Commun 243:503–508
Mori S, Rönnstrand L, Yokote K, Engström A, Courtneidge SA, Claesson-Welsh L, Heldin CH (1993) Identification of two juxtamembrane autophosphorylation sites in the PDGFβ-receptor; involvement in the interaction with Src family tyrosine kinases. EMBO J 12:2257–2264
Muthuswamy SK, Siegel PM, Dankort DL, et al. (1994) Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity. Mol Cell Biol 14:735–743
Nakagawa T, Tanaka S, Suzuki H, Takayanagi H, Miyazaki T, Nakamura K, Tsuruo T (2000) Overexpression of the csk gene suppresses tumor metastasis in vivo. Int J Cancer 88:384–391
Nigg EA, Sefton BM, Hunter T, et al. (1982) Immunofluorescent localization of the transforming protein of Rous sarcoma virus with antibodies against a synthetic src peptide. Proc Natl Acad Sci USA 79:5322–5326
Noritake H, Miyamori H, Goto C, et al. (1999) Overexpression of tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) in metastatic MDCK cells transformed by v-src. Clin Exp Metastasis 17:105–110
Perl AK, Wilgenbus P, Dahl U, et al. (1998) A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392:190–193
Rous PA (1911a) Transmission of a malignant new growth by means of a cell-free filtrate. JAMA 56:198
Rous PA (1911b) A sarcoma of the fowl transmissible by an agent separable from the tumor cells. J Exp Med 13:397–411
Rubin H (1955) Quantitative relations between causative virus and cell in the Rous No. 1 chicken sarcoma. Virology 6:669–688
Sastry SK, Burridge K (2000) Focal adhesions: a nexus for intracellular signaling and cytoskeletal dynamics. Exp Cell Res 261:25–36
Sefton BM, Trowbridge IS, Cooper JA, Scolnick EM (1982) The transforming proteins of Rous sarcoma virus, Harvey sarcoma virus and Abelson virus contain tightly bound lipid. Cell 31:465–474
Summy JM, Gallick GE (2003) Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev 22:337–358
Summy JM, Trevino JG, Lesslie DP, et al. (2005) AP23846, a novel and highly potent Src family kinase inhibitor, reduces vascular endothelial growth factor and interleukin-8 expression in human solid tumor cell lines and abrogates downstream angiogenic processes. Mol Cancer Ther 4:1900–1911
Takeya T, Hanafusa H (1982) DNA sequence of the viral and cellular src gene of chickens. 2. Comparison of the src genes of two strains of avian sarcoma virus and of the cellular homolog. J Virol 44:12–18
Takeya T, Feldman RA, Hanafausa H (1982) DNA sequence of the viral and cellular src gene of chickens. 1. Complete nucleotide sequence of an EcoRI fragment of recovered avian sarcoma virus which codes for gp37 and pp60src. J Virol 44:1–11
Thomas JW, Ellis B, Boerner RJ, Knight WB, White GC, Schaller MD (1998) SH2- and SH3-mediated interactions between focal adhesion kinase and Src. J Biol Chem 273:577–583
Tice DA, Biscardi JS, Nickles AL, Parsons SJ (1999) Mechanism of biological synergy between cellular Src and epidermal growth factor receptor. Proc Natl Acad Sci USA 96:1415–1420
Varmus HE, Quintrell N, Wyke J (1981) Revertants of an ASV-transformed rat cell line have lost the complete provirus or sustained mutations in src. Virology 108:28–46
Yamaguchi H, Hendrickson WA (1996) Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation. Nature 384:484–489
Yezhelyev MV, Koehl G, Guba M, et al. (2004) Inhibition of SRC tyrosine kinase as treatment for human pancreatic cancer growing orthotopically in nude mice. Clin Cancer Res 10:8028–8036
Zheng XM, Wang Y, Pallen CJ (1992) Cell transformation and activation of pp60c-src by overexpression of a protein tyrosine phosphatase. Nature 359:336–339
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hilbig, A. (2008). Src Kinase and Pancreatic Cancer. In: Pancreatic Cancer. Recent Results in Cancer Research, vol 177. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-71279-4_19
Download citation
DOI: https://doi.org/10.1007/978-3-540-71279-4_19
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-71266-4
Online ISBN: 978-3-540-71279-4
eBook Packages: MedicineMedicine (R0)